Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311679080> ?p ?o ?g. }
- W4311679080 endingPage "e0278693" @default.
- W4311679080 startingPage "e0278693" @default.
- W4311679080 abstract "Renal excretion of direct oral anticoagulants (DOACs) varies depending on the drug. Hypothetically, an increased glomerular filtration rate (GFR) may lead to suboptimal dosing and a higher thromboembolic events incidence. However, real-world patient data do not support the theoretical risk. The aim is to analyse DOAC outcomes in patients with normal and high (≥90 mL/min) GFR, focusing on biological parameters and thrombotic/haemorrhagic events.Observational prospective single-centre study and registry of patients on DOACs. Follow-up was 1,343 patient-years. A bivariate analysis was performed of baseline variables according to GFR (<90 mL/min vs ≥90 mL/min). Anti-Xa activity before and after drug intake (HemosIL, Liquid Anti-Xa, Werfen) was measured for edoxaban, apixaban, and rivaroxaban; diluted thrombin time for dabigatran (HEMOCLOT); and additionally, plasma concentrations in edoxaban (HemosIl, Liquid Anti-Xa suitably calibrated).1,135 patients anticoagulated with DOACs were included and 152 patients with GFR ≥90 mL/min. Of 18 serious thrombotic complications during follow-up, 17 occurred in patients with GFR <90 mL/min, and 1 in a patient with GFR ≥90 mL/min. A higher incidence of complications was observed in patients with normal GFR, but the difference was not statistically significant (p>0.05). No statistically significant differences with clinical relevance were observed between the normal or supranormal groups in anti-Xa activity or in edoxaban plasma concentrations.There was no increased incidence of thrombotic/haemorrhagic complications in our patients treated with DOACs, including 66% treated with edoxaban, and patients with GFR ≥90 mL/min. Likewise, drug anti-Xa activity and edoxaban plasma concentration did not seem to be influenced by GFR." @default.
- W4311679080 created "2022-12-28" @default.
- W4311679080 creator A5004852788 @default.
- W4311679080 creator A5005180833 @default.
- W4311679080 creator A5007925672 @default.
- W4311679080 creator A5032163383 @default.
- W4311679080 creator A5061307677 @default.
- W4311679080 creator A5085428094 @default.
- W4311679080 creator A5091670743 @default.
- W4311679080 date "2022-12-09" @default.
- W4311679080 modified "2023-09-26" @default.
- W4311679080 title "Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants" @default.
- W4311679080 cites W1723667168 @default.
- W4311679080 cites W1917850483 @default.
- W4311679080 cites W2026766534 @default.
- W4311679080 cites W2097854437 @default.
- W4311679080 cites W2116559262 @default.
- W4311679080 cites W2130492862 @default.
- W4311679080 cites W2136489990 @default.
- W4311679080 cites W2152623033 @default.
- W4311679080 cites W2162508946 @default.
- W4311679080 cites W2162586165 @default.
- W4311679080 cites W2179850291 @default.
- W4311679080 cites W2194419520 @default.
- W4311679080 cites W2472624475 @default.
- W4311679080 cites W2594876785 @default.
- W4311679080 cites W2595447138 @default.
- W4311679080 cites W2613707826 @default.
- W4311679080 cites W2785329027 @default.
- W4311679080 cites W2786491861 @default.
- W4311679080 cites W2886106988 @default.
- W4311679080 cites W2890093579 @default.
- W4311679080 cites W2895123572 @default.
- W4311679080 cites W2911153667 @default.
- W4311679080 cites W2952641308 @default.
- W4311679080 cites W2992523246 @default.
- W4311679080 cites W3164696667 @default.
- W4311679080 cites W3213876493 @default.
- W4311679080 cites W4200393364 @default.
- W4311679080 doi "https://doi.org/10.1371/journal.pone.0278693" @default.
- W4311679080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36490245" @default.
- W4311679080 hasPublicationYear "2022" @default.
- W4311679080 type Work @default.
- W4311679080 citedByCount "0" @default.
- W4311679080 crossrefType "journal-article" @default.
- W4311679080 hasAuthorship W4311679080A5004852788 @default.
- W4311679080 hasAuthorship W4311679080A5005180833 @default.
- W4311679080 hasAuthorship W4311679080A5007925672 @default.
- W4311679080 hasAuthorship W4311679080A5032163383 @default.
- W4311679080 hasAuthorship W4311679080A5061307677 @default.
- W4311679080 hasAuthorship W4311679080A5085428094 @default.
- W4311679080 hasAuthorship W4311679080A5091670743 @default.
- W4311679080 hasBestOaLocation W43116790801 @default.
- W4311679080 hasConcept C120665830 @default.
- W4311679080 hasConcept C121332964 @default.
- W4311679080 hasConcept C126322002 @default.
- W4311679080 hasConcept C126894567 @default.
- W4311679080 hasConcept C159641895 @default.
- W4311679080 hasConcept C2776301958 @default.
- W4311679080 hasConcept C2776710957 @default.
- W4311679080 hasConcept C2777288759 @default.
- W4311679080 hasConcept C2778661090 @default.
- W4311679080 hasConcept C2778810321 @default.
- W4311679080 hasConcept C2779161974 @default.
- W4311679080 hasConcept C2780290652 @default.
- W4311679080 hasConcept C2780638905 @default.
- W4311679080 hasConcept C61511704 @default.
- W4311679080 hasConcept C71924100 @default.
- W4311679080 hasConcept C90924648 @default.
- W4311679080 hasConceptScore W4311679080C120665830 @default.
- W4311679080 hasConceptScore W4311679080C121332964 @default.
- W4311679080 hasConceptScore W4311679080C126322002 @default.
- W4311679080 hasConceptScore W4311679080C126894567 @default.
- W4311679080 hasConceptScore W4311679080C159641895 @default.
- W4311679080 hasConceptScore W4311679080C2776301958 @default.
- W4311679080 hasConceptScore W4311679080C2776710957 @default.
- W4311679080 hasConceptScore W4311679080C2777288759 @default.
- W4311679080 hasConceptScore W4311679080C2778661090 @default.
- W4311679080 hasConceptScore W4311679080C2778810321 @default.
- W4311679080 hasConceptScore W4311679080C2779161974 @default.
- W4311679080 hasConceptScore W4311679080C2780290652 @default.
- W4311679080 hasConceptScore W4311679080C2780638905 @default.
- W4311679080 hasConceptScore W4311679080C61511704 @default.
- W4311679080 hasConceptScore W4311679080C71924100 @default.
- W4311679080 hasConceptScore W4311679080C90924648 @default.
- W4311679080 hasFunder F4320338262 @default.
- W4311679080 hasIssue "12" @default.
- W4311679080 hasLocation W43116790801 @default.
- W4311679080 hasLocation W43116790802 @default.
- W4311679080 hasLocation W43116790803 @default.
- W4311679080 hasOpenAccess W4311679080 @default.
- W4311679080 hasPrimaryLocation W43116790801 @default.
- W4311679080 hasRelatedWork W1888436343 @default.
- W4311679080 hasRelatedWork W2153511638 @default.
- W4311679080 hasRelatedWork W2164414335 @default.
- W4311679080 hasRelatedWork W2311379003 @default.
- W4311679080 hasRelatedWork W2331860615 @default.
- W4311679080 hasRelatedWork W2334299535 @default.